Cargando…
Treatment considerations for patients with pemphigus during the COVID-19 pandemic
Autores principales: | Shakshouk, Hadir, Daneshpazhooh, Maryam, Murrell, Dedee F., Lehman, Julia S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
by the American Academy of Dermatology, Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7146668/ https://www.ncbi.nlm.nih.gov/pubmed/32283243 http://dx.doi.org/10.1016/j.jaad.2020.04.005 |
Ejemplares similares
-
Authors' reply to the comment “Treatment considerations for patients with pemphigus during the COVID-19 pandemic”
por: Shakshouk, Hadir, et al.
Publicado: (2021) -
Reply to “Treatment considerations for patients with pemphigus during the COVID-19 pandemic”
por: Schultz, Brittney, et al.
Publicado: (2021) -
Reply to: “Biologics for psoriasis during COVID-19 outbreak”
por: Murrell, Dedee F., et al.
Publicado: (2020) -
Reply to: “COVID-19, syphilis, and biologic therapies for psoriasis and psoriatic arthritis: A word of caution”
por: Lebwohl, Mark, et al.
Publicado: (2020) -
Adalimumab for treatment of hidradenitis suppurativa during the COVID-19 pandemic: Safety considerations
por: Blaszczak, Alecia, et al.
Publicado: (2020)